General MedicationsORALStandard
ISRADIPINE
ISRADIPINE
Standard Dose
2.5MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary
Approval overview ISRADIPINE is listed in Drugs@FDA under application 077317 (ANDA).
Marketing status: Prescription Active ingredient ISRADIPINE Form and strength CAPSULE;ORAL - 2.5MG Sponsor WATSON LABS TEVA Submission history Latest submission status date: 2006-01-05 00:00:00.
Structured Monograph
Clinical summary
Approval overview ISRADIPINE is listed in Drugs@FDA under application 077317 (ANDA). Marketing status: Prescription Active ingredient ISRADIPINE Form and strength CAPSULE;ORAL - 2.5MG Sponsor WATSON LABS TEVA Submission history Latest submission status date: 2006-01-05 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
Interaction Notes
- No interaction notes stored yet.